Phrenic nerve stimulation in CRT patients and benefits of electronic lead repositioning: the ERACE trial

Despite novel left ventricular (LV) lead technologies, phrenic nerve stimulation (PNS) remains an adverse effect observed in many patients with cardiac resynchronization therapy (CRT). Beyond anatomic repositioning, modern CRT devices allow avoidance of PNS also by software-based adaption of the pac...

Full description

Saved in:
Bibliographic Details
Main Authors: Götze, Stephan (Author) , Defaye, Pascal (Author) , Bauer, Alexander (Author) , Merkel, Matthias (Author) , Bizeau, Olivier (Author) , Treusch, Sven (Author) , Contzen, Klaus (Author) , Jünger, Claus Heinrich (Author) , Winter, Joachim (Author)
Format: Article (Journal)
Language:English
Published: 19 July 2013
In: Journal of interventional cardiac electrophysiology
Year: 2013, Volume: 38, Pages: 1-9
ISSN:1572-8595
DOI:10.1007/s10840-013-9811-9
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s10840-013-9811-9
Get full text
Author Notes:Stephan Goetze, Pascal Defaye, Alexander Bauer, Matthias Merkel, Olivier Bizeau, Sven Treusch, Klaus Contzen, Claus Juenger, Joachim Winter, on behalf of the ERACE study investigators
Description
Summary:Despite novel left ventricular (LV) lead technologies, phrenic nerve stimulation (PNS) remains an adverse effect observed in many patients with cardiac resynchronization therapy (CRT). Beyond anatomic repositioning, modern CRT devices allow avoidance of PNS also by software-based adaption of the pacing configuration. The Electronic Repositioning With Acuity and Easytrak Leads study evaluated the incidence of PNS in a CRT population and examined how often LV lead relocation can be avoided by “electronic repositioning” (ER).
Item Description:Gesehen am 12.02.2020
Physical Description:Online Resource
ISSN:1572-8595
DOI:10.1007/s10840-013-9811-9